Four-antigen mixture containing V-cyclin for serological screening of human herpesvirus 8 infection

Clinical and Vaccine Immunology

Volumn 16, Issue 5, 2009, Pages 621-627

  Burbelo, Peter D ^a,d   Leahy, Hannah P ^a   Groot, Sandra ^a   Bishop, Lisa R ^c   Miley, Wendell ^b   Iadarola, Michael J ^a   Whitby, Denise ^b   Kovacs, Joseph A ^c  

^a National Institutes of Dental and Craniofacial Research   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; LATENCY ASSOCIATED NUCLEAR ANTIGEN; PROTEIN ANTIBODY; PROTEIN HHV 8; PROTEIN K 8.1; PROTEIN ORF 65; PROTEIN V CYCLIN; UNCLASSIFIED DRUG; V CYCLIN ANTIBODY; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACULOVIRUS; CELL HETEROGENEITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMORAL IMMUNITY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 66849131595     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00474-08     Document Type: Article

References (26)

1. Burbelo, P. D., K. H. Ching, T. L. Mattson, J. S. Light, L. R. Bishop, and J. A. Kovacs. 2007. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipi- tation systems). Biochem. Biophys. Res. Commun. 352:889-895.
2. Burbelo, P. D., R. Goldman, and T. L. Mattson. 2005. A simplified immu- noprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-anti- gen fusion proteins. BMC Biotechnol. 5:22.
3. Burbelo, P. D., S. Groot, M. C. Dalakas, and M. J. Iadarola. 2008. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem. Biophys. Res. Commun. 366:1-7.
4. Burbelo, P. D., H. Hirai, H. Leahy, A. Lernmark, S. A. Ivarsson, M. J. Iadarola, and A. L. Notkins. 2008. A new luminescence assay for autoanti- bodies to mammalian cell-prepared insulinoma-associated protein 2. Diabetes Care 31:1824-1826.
5. Burbelo, P. D., Y. Hoshino, H. Leahy, T. Krogmann, R. L. Hornung, M. J. Iadarola, and J. I. Cohen. 2009. Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin. Vaccine Immunol. 16:366-371.
6. Burbelo, P. D., E. Meoli, H. P. Leahy, J. Graham, K. Yao, U. Oh, J. E. Janik, R.Mahieux, F. Kasanchi, M. J. Iadarola, and S. Jacobson. 2008. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelop- athy/tropical spastic paraparesis (HAM/TSP). Retrovirology 5:96.
7. Burbelo, P. D., R. Ramanathan, A. D. Klion, M. J. Iadarola, and T. B.Nutman. 2008. Rapid, novel, specific, high-throughput assay for diagnosis of loa loa infection. J. Clin. Microbiol. 46:2298-2304.
8. Coscoy, L. 2007. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat. Rev. Immunol. 7:391-401.
9. de Souza, V. A., L. C. Pierrotti, L. M. Sumita, W. S. Freire, A. A. Segurado,and C. S. Pannuti. 2007. Seroreactivity to Kaposi's sarcoma-associated her- pesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count. J. Med. Virol.79:1562-1568.
10. Dittmer, D. P. 2003. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res. 63:2010-2015.
11. Engels, E. A., D. Whitby, P. B. Goebel, A. Stossel, D. Waters, A. Pintus, L. Contu, R. J. Biggar, and J. J. Goedert. 2000. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J. Acquir. Immune Defic. Syndr. 23:346-354.
12. Ganem, D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma.Annu. Rev. Pathol. 1:273-296.
13. Gao, S. J., L. Kingsley, M. Li, W. Zheng, C. Parravicini, J. Ziegler, R. Newton, C. R. Rinaldo, A. Saah, J. Phair, R. Detels, Y. Chang, and P. S.Moore. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 2:925-928.
14. Hladik, W., S. C. Dollard, J. Mermin, A. L. Fowlkes, R. Downing, M. M.Amin, F. Banage, E. Nzaro, P. Kataaha, T. J. Dondero, P. E. Pellett, and E. M. Lackritz. 2006. Transmission of human herpesvirus 8 by blood transfusion. N. Engl. J. Med. 355:1331-1338.
15. Jenkins, F. J., R. B. Hayes, A. Jackson, G. Pizza, G. Mbisa, D. Whitby, and J. J. Goedert. 2007. Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J. Infect. Dis. 196:208-211.
16. Katano, H., T. Iwasaki, N. Baba, M. Terai, S. Mori, A. Iwamoto, T. Kurata, and T. Sata. 2000. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J. Virol. 74:3478-3485.
17. Koopal, S., J. H. Furuhjelm, A. Jarviluoma, S. Jaamaa, P. Pyakurel, C. Pussinen, M. Wirzenius, P. Biberfeld, K. Alitalo, M. Laiho, and P. M. Ojala.2007. Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog. 3:1348-1360.
18. Laney, A. S., J. S. Peters, S. M. Manzi, L. A. Kingsley, Y. Chang, and P. S.Moore. 2006. Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J. Clin. Microbiol. 44:3734-3741.
19. Martin, J. N., Z. Amad, C. Cossen, P. K. Lam, D. H. Kedes, K. A. Page-Shafer, D. H. Osmond, and B. Forghani. 2000. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J. Clin. Microbiol. 38:696-701.
20. Martro, E., M. J. Cannon, S. C. Dollard, T. J. Spira, A. S. Laney, C. Y. Ou, and P. E. Pellett. 2004. Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection. J. Virol. 78: 11707-11714.
21. Moore, P. S., and Y. Chang. 2003. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu. Rev. Microbiol. 57:609-639.
22. Pfeiffer, R. M., R. J. Carroll, W. Wheeler, D. Whitby, and S. Mbulaiteye.2008. Combining assays for estimating prevalence of human herpesvirus 8 infection using multivariate mixture models. Biostatistics 9:137-151.
23. Rabkin, C. S., T. F. Schulz, D. Whitby, E. T. Lennette, L. I. Magpantay, L.Chatlynne, R. J. Biggar, et al. 1998. Interassay correlation of human herpesvirus 8 serologic tests. J. Infect. Dis. 178:304-309.
24. Ramanathan, R., P. D. Burbelo, S. Groot, M. J. Iadarola, F. A. Neva, and T. B. Nutman. 2008. A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercorals infection. J. Infect. Dis. 198:444-451.
25. Smith, N. A., C. A. Sabin, R. Gopal, D. Bourboulia, W. Labbet, C. Boshoff, D. Barlow, B. Band, B. S. Peters, A. de Ruiter, D. W. Brown, R. A. Weiss,J. M. Best, and D. Whitby. 1999. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J. Infect. Dis. 180:600-606.
26. Zhu, L., R. Wang, A. Sweat, E. Goldstein, R. Horvat, and B. Chandran. 1999.Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 256:381-392